<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Skin and Venereal Diseases</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Skin and Venereal Diseases</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский журнал кожных и венерических болезней</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1560-9588</issn><issn publication-format="electronic">2412-9097</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">624169</article-id><article-id pub-id-type="doi">10.17816/dv624169</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>DERMATOLOGY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ДЕРМАТОЛОГИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Prevalence and clinical signs of inflammatory back pain in patients with skin psoriasis and axial involvement</article-title><trans-title-group xml:lang="ru"><trans-title>Распространённость и клиническая характеристика воспалительной боли в спине у пациентов с псориазом кожи</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1563-9475</contrib-id><contrib-id contrib-id-type="spin">8923-7850</contrib-id><name-alternatives><name xml:lang="en"><surname>Pereverzina</surname><given-names>Natalia O.</given-names></name><name xml:lang="ru"><surname>Переверзина</surname><given-names>Наталья Олеговна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>кандидат медицинских наук</p></bio><email>natalia.pereverzina@gmail.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5044-5265</contrib-id><contrib-id contrib-id-type="spin">1107-4372</contrib-id><name-alternatives><name xml:lang="en"><surname>Kruglova</surname><given-names>Larisa S.</given-names></name><name xml:lang="ru"><surname>Круглова</surname><given-names>Лариса Сергеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.), Associated Professor</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, доцент</p></bio><email>kruglovals@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0579-1131</contrib-id><contrib-id contrib-id-type="spin">9855-5954</contrib-id><name-alternatives><name xml:lang="en"><surname>Korotaeva</surname><given-names>Tatiana V.</given-names></name><name xml:lang="ru"><surname>Коротаева</surname><given-names>Татьяна Викторовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>доктор медицинских наук</p></bio><email>tatianakorotaeva@googlemail.com</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Central State Medical Academy of Department of Presidential Affairs</institution></aff><aff><institution xml:lang="ru">Центральная государственная медицинская академия Управления делами Президента Российской Федерации</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">The National Medical Research Center for Otorhinolaryngology</institution></aff><aff><institution xml:lang="ru">Национальный медицинский исследовательский центр оториноларингологии Федерального медико-биологического агентства России</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">V.A. Nasonova Research Institute of Rheumatology</institution></aff><aff><institution xml:lang="ru">Научно-исследовательский институт ревматологии имени В.А. Насоновой</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2024-01-12" publication-format="electronic"><day>12</day><month>01</month><year>2024</year></pub-date><volume>27</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>69</fpage><lpage>82</lpage><history><date date-type="received" iso-8601-date="2023-12-02"><day>02</day><month>12</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2024-01-19"><day>19</day><month>01</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Эко-Вектор</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2027-01-04"/></permissions><self-uri xlink:href="https://rjsvd.com/1560-9588/article/view/624169">https://rjsvd.com/1560-9588/article/view/624169</self-uri><abstract xml:lang="en"><p><bold>BACKGROUND</bold>: The incidence of psoriatic arthritis has been increasing in recent years. Moreover the number of severe cases resistant to standard therapy has been increasing as well and leading to a marked deterioration in the quality of life and early disability. There is a need to diagnose the disease at preclinical stages, as well as early therapy and secondary prevention. Therefore, the role of dermatologists in identifying predictors and risk factors for the development and severe course of psoriatic arthritis is increasing. Particularly severe forms of psoriatic arthritis are caused by axial manifestations, which are often clinically asymptomatic in early stage of psoriatic arthritis. Moreover, most often axial manifestations is diagnosed in patients with an already established diagnosis of psoriatic arthritis, and there is practically no data on the prevalence and clinical and instrumental characteristics of axial manifestations in patients with smooth skin psoriasis.</p> <p><bold>AIM:</bold> to assess the prevalence and clinical characteristic of axial manifestations in patients with skin psoriasis using questionnaires, scales and Аssessment of SpondyloArthritis International Society (ASAS) diagnostic criteria.</p> <p><bold>MATERIALS AND METHODS:</bold> The prospective study to assess the prevalence and clinical characteristiс of axial manifestations in patients with skin psoriasis.</p> <p><bold>RESULTS:</bold> The prevalence of axial manifestations in patients with skin psoriasis, according to ASAS criteria, was 36.1%. Early manifestations of axial lesions in patients with skin psoriasis are aching, nagging pain in the back (37.2%) or neck (22.1%), as well as a feeling of stiffness in the back (46.3%) or neck (38.9%). The main risk factors and predictors of the development of psoriatic arthritis were the long duration of skin psoriasis (more than 12 years), pain in any joints, swelling of the fingers, pain/stiffness in the neck, pain/stiffness in the back, pain in the joints at rest/night time, widespread (BSA &gt;18 points), severe (PASI &gt;13 points) process. Having back/neck pain at rest or at night increases the odds of developing inflammatory pain by 132 times and 10 times, respectively, and back/neck stiffness by 10 and 6 times, respectively. Increasing the age of onset of back/neck pain by 1 year increases the chances of developing axial lesions by 1.3 times.</p> <p><bold>CONCLUSION:</bold> There is the first study to identify clinical signs of inflammatory back pain in patient with axial manifestations at early stage of psoriatic arthritis and to determine the prevalence of inflammatory back pain in patients with skin psoriasis and without an established diagnosis of psoriatic arthritis. However, further study of methods for early diagnosis of axial manifestations and other forms of psoriatic arthritis is necessary to optimize treatment and improve the quality of life of patients.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование.</bold> В последние годы отмечается рост заболеваемости псориатическим артритом, увеличивается число случаев его тяжёлого, устойчивого к стандартной терапии течения, приводящего к выраженному ухудшению качества жизни, потере трудоспособности, ранней инвалидизации. Возникает необходимость как диагностики заболевания на доклинических стадиях, так и ранней терапии и вторичной профилактики. Именно поэтому всё больше возрастает роль врачей-дерматовенерологов в выявлении предикторов и факторов риска развития и тяжёлого течения псориатического артрита. Аксиальные поражения, протекающие часто на ранних стадиях псориатического артрита клинически малосимптомно, обусловливают особенно тяжёлые его формы. Более того, чаще всего аксиальные поражения диагностируют у пациентов с уже установленным диагнозом псориатического артрита, а данных о распространённости и клинико-инструментальной характеристике аксиальных поражений у больных псориазом гладкой кожи практически нет.</p> <p><bold>Цель исследования ― </bold>изучить распространённость и клиническую характеристику воспалительной боли в спине при аксиальных поражениях у больных псориазом кожи.</p> <p><bold>Материалы и методы.</bold> Нами проведено проспективное исследование с оценкой распространённости и клинической характеристикой воспалительной боли в спине у пациентов с псориазом кожи и аксиальными поражениями по данным опросников, шкал и диагностических критериев ASAS.</p> <p><bold>Результаты.</bold> Распространённость аксиальных поражений у больных псориазом кожи, согласно критериям Международного общества по изучению спондилоартритов (ASAS), составила 36,1%. Ранними проявлениями аксиальных поражений являются ноющая, тянущая боль в спине (37,2%) или шее (22,1%), а также чувство скованности в спине (46,3%) или шее (38,9%). Помимо длительности заболевания (более 12 лет), к основным факторам риска и предикторам развития псориатического артрита можно отнести боль в любых суставах, припухание пальцев, боль/скованность в шее, боль/скованность в спине, боль в суставах в покое/ночное время, распространённый (BSA &gt;18 баллов), тяжёлый (PASI &gt;13 баллов) процесс. Наличие болей в спине/шее в покое или ночью увеличивает шансы развития воспалительной боли в 132 и 10 раз, наличие скованности в спине/шее ― в 10 и 6 раз соответственно. Увеличение возраста появления болей в спине/шее на 1 год повышают шансы формирования аксиальных поражений в 1,3 раза.</p> <p><bold>Заключение.</bold> В нашей работе впервые были определены клинические признаки воспалительной боли в позвоночнике при аксиальных поражениях, характерных для псориатического артрита, а также распространённость воспалительной боли в спине у пациентов с псориазом гладкой кожи и без установленного диагноза псориатического артрита. Однако необходимо дальнейшее изучение способов ранней диагностики аксиальных поражений и других форм псориатического артрита для оптимизации лечения и улучшения качества жизни пациентов.</p></trans-abstract><kwd-group xml:lang="en"><kwd>psoriasis</kwd><kwd>psoriatic arthritis</kwd><kwd>axial manifestations</kwd><kwd>inflammatory back pain</kwd><kwd>sacroiliitis</kwd><kwd>spondylitis</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>псориаз кожи</kwd><kwd>псориатический артрит</kwd><kwd>аксиальные поражения</kwd><kwd>воспалительная боль в спине</kwd><kwd>сакроилеит</kwd><kwd>спондилит</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Veale DJ, Fearon U. The pathogenesis of psoriatic arthritis. Lancet. 2018;391(10136):2273-2284. doi: 10.1016/S0140-6736(18)30830-4</mixed-citation><mixed-citation xml:lang="ru">Veale D.J., Fearon U. The pathogenesis of psoriatic arthritis // Lancet. 2018. Vol. 391, N 10136. P. 2273-2284. doi: 10.1016/S0140-6736(18)30830-4</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Mishina OS, Korotaeva TV, Starodubov VI, Nasonov EL. Incidence of psoriatic arthritis in Russia: Trends at the present stage and prospects. Rheumatol Sci Pract. 2015;53(3):251-257. EDN: UIEIDL doi: 10.14412/1995-4484-2015-251-257</mixed-citation><mixed-citation xml:lang="ru">Мишина О.С., Коротаева Т.В., Стародубов В.И., Насонов Е.Л. Заболеваемость псориатическим артритом в России: тенденции на современном этапе и перспективы // Научно-практическая ревматология. 2015. Т. 53, № 3. C. 251-257. EDN: UIEIDL doi: 10.14412/1995-4484-2015-251-257</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Tillett W, Charlton R, Nightingale A. Interval between onset of psoriasis and psoriatic arthritis comparing the UK Clinical Practice Research Datalink with a hospital-based cohort. Rheumatology (Oxford). 2017;56(12):2109-2113. doi: 10.1093/rheumatology/kex323</mixed-citation><mixed-citation xml:lang="ru">Tillett W., Charlton R., Nightingale A. Interval between onset of psoriasis and psoriatic arthritis comparing the UK Clinical Practice Research Datalink with a hospital-based cohort // Rheumatology (Oxford). 2017. Vol. 56, N 12. P. 2109-2113. doi: 10.1093/rheumatology/kex323</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Koreshkova KM, Khismatullina ZR. Quality of life in patients with psoriatic arthritis. Vestnik dermatologii i venerologii. 2021;97(3):56-65. EDN: EUORBI doi: 10.25208/vdv1213</mixed-citation><mixed-citation xml:lang="ru">Корешкова К.М., Хисматуллина З.Р. Качество жизни у больных псориатическим артритом // Вестник дерматологии и венерологии. 2021. Т. 97, № 3. C. 56-65. EDN: EUORBI doi: 10.25208/vdv1213</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Martin BI, Deyo RA, Mirza SK, et al. Expenditures and health status among adults with back and neck problems. JAMA. 2008;299(6):656-664. doi: 10.1001/jama.299.6.656</mixed-citation><mixed-citation xml:lang="ru">Martin B.I., Deyo R.A., Mirza S.K., et al. Expenditures and health status among adults with back and neck problems // JAMA. 2008. Vol. 299, N 6. P. 656-664. doi: 10.1001/jama.299.6.656</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Luo X, Pietrobon R, Sun SX, et al. Estimates and patterns of direct health care expenditures among individuals with back pain in the United States. Spine (Phila Pa 1976). 2004;29(1):79-86. doi: 10.1097/01.BRS.0000105527.13866.0F</mixed-citation><mixed-citation xml:lang="ru">Luo X., Pietrobon R., Sun S.X., et al. Estimates and patterns of direct health care expenditures among individuals with back pain in the United States // Spine (Phila Pa 1976). 2004. Vol. 29, N 1. P. 79-86. doi: 10.1097/01.BRS.0000105527.13866.0F</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Loginova E, Korotaeva TV, Smirnov AV, et al. Specific features of axial skeleton involvement in early psoriatic arthritis (the REMARCA trial). Rheumatol Sci Pract. 2016;54(S1):15-19. EDN: WXHHHN doi: 10.14412/1995-4484-2016-1S-15-19</mixed-citation><mixed-citation xml:lang="ru">Логинова Е.Ю., Коротаева Т.В., Смирнов А.В., и др. Особенности поражения осевого скелета при раннем псориатическом артрите (исследование РЕМАРКА) // Научно-практическая ревматология. 2016. Т. 54, № S1. С. 15-19. EDN: WXHHHN doi: 10.14412/1995-4484-2016-1S-15-19</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Belinchón I, Salgado-Boquete L, López-Ferrer A, et al. Dermatologists’ role in the early diagnosis of psoriatic arthritis: Expert recommendations. Actas Dermosifiliogr (Engl Ed). 2020;111(10):835-846. doi: 10.1016/j.ad.2020.06.004</mixed-citation><mixed-citation xml:lang="ru">Belinchón I., Salgado-Boquete L., López-Ferrer A., et al. Dermatologists’ role in the early diagnosis of psoriatic arthritis: Expert recommendations // Actas Dermosifiliogr (Engl Ed). 2020. Vol. 111, N 10. P. 835-846. doi: 10.1016/j.ad.2020.06.004</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Chamurlieva MN, Loginova EY, Korotaeva TV. Detectability of the peripheral and axial manifestations of psoriatic arthritis in patients with psoriasis in dermatological practice. Modern Rheumatol J. 2019;13(4):48-54. EDN: MKVNBR doi: 10/14412/1996-7012-2019-4-48-54</mixed-citation><mixed-citation xml:lang="ru">Чамурлиева М.Н., Логинова Е.Ю., Коротаева Т.В. Выявляемость периферических и аксиальных проявлений псориатического артрита у больных псориазом в дерматологической практике // Современная ревматология. 2019. Т. 13, № 4. С. 48-54. EDN: MKVNBR doi: 10/14412/1996-7012-2019-4-48-54</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Bagel J, Schwartzman S. Enthesitis and dactylitis in psoriatic disease: A guide for dermatologists. Am J Clin Dermatol. 2018;19(6):839-852. EDN: KVBAQO doi: 10.1007/s40257-018-0377-2</mixed-citation><mixed-citation xml:lang="ru">Bagel J., Schwartzman S. Enthesitis and dactylitis in psoriatic disease: A guide for dermatologists // Am J Clin Dermatol. 2018. Vol. 19, N 6. P. 839-852. EDN: KVBAQO doi: 10.1007/s40257-018-0377-2</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Van der Heijde D, Ramiro S, Landewe R, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76(6):978-991. EDN: YDRYYK doi: 10.1136/annrheumdis-2016-210770</mixed-citation><mixed-citation xml:lang="ru">Van der Heijde D., Ramiro S., Landewe R., et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis // Ann Rheum Dis. 2017. Vol. 76, N 6. P. 978-991. EDN: YDRYYK doi: 10.1136/annrheumdis-2016-210770</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Jadon D, Sengupta R, Nightingale A, et al. Axial disease in psoriatic arthritis study: Defining the clinical and radiographic phenotype of psoriatic spondyloarthritis. Ann Rheum Dis. 2017;76(4):701-707. doi: 10.1136/annrheumdis-2016-209853</mixed-citation><mixed-citation xml:lang="ru">Jadon D., Sengupta R., Nightingale A., et al. Axial disease in psoriatic arthritis study: Defining the clinical and radiographic phenotype of psoriatic spondyloarthritis // Ann Rheum Dis. 2017. Vol. 76, N 4. P. 701-707. doi: 10.1136/annrheumdis-2016-209853</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Chamurlieva MN, Loginova EY, Korotaeva TV. Detection rates of psoriatic arthritis in patients with psoriasis in a dermatology and rheumatology clinic. Modern Rheumatol J. 2016;10(4):47-50. EDN: XEKFAH doi: 10.14412/1996-7012-2016-4-47-50</mixed-citation><mixed-citation xml:lang="ru">Чамурлиева М.Н., Логинова Е.Ю., Коротаева Т.В. Выявляемость псориатического артрита у больных псориазом в дерматологической и ревматологической клинике // Современная ревматология. 2016. Т. 10, № 4. C. 47-50. EDN: XEKFAH doi: 10.14412/1996-7012-2016-4-47-50</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Chamurlieva MN, Loginova EY, Korotaeva TV. Detectability of the peripheral and axial manifestations of psoriatic arthritis in patients with psoriasis in dermatological practice. Modern Rheumatol J. 2019;13(4):48-54. EDN: MKVNBR doi: 10.14412/1996-7012-2019-4-48-54</mixed-citation><mixed-citation xml:lang="ru">Чамурлиева М.Н., Логинова Е.Ю., Коротаева Т.В. Выявляемость периферических и аксиальных проявлений псориатического артрита у больных псориазом в дерматологической практике // Современная ревматология. 2019. Т. 13, № 4. С. 48-54. EDN: MKVNBR doi: 10.14412/1996-7012-2019-4-48-54</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Chandran V, Tolusso DC, Cook RJ, Gladman DD. Risk factors for axial inflammatory arthritis in patients with psoriatic arthritis. J Rheumatol. 2010;37(4):809-815. doi: 10.3899/jrheum.091059</mixed-citation><mixed-citation xml:lang="ru">Chandran V., Tolusso D.C., Cook R.J., Gladman D.D. Risk factors for axial inflammatory arthritis in patients with psoriatic arthritis // J Rheumatol. 2010. Vol. 37, N 4. P. 809-815. doi: 10.3899/jrheum.091059</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Chandran V, Barrett J, Schentag CT, et al. Axial psoriatic arthritis: Update on a longterm prospective study. J Rheumatol. 2009;36(12):2744-2750. doi: 10.3899/jrheum.090412</mixed-citation><mixed-citation xml:lang="ru">Chandran V., Barrett J., Schentag C.T., et al. Axial psoriatic arthritis: Update on a longterm prospective study // J Rheumatol. 2009. Vol. 36, N 12. P. 2744-2750. doi: 10.3899/jrheum.090412</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Chyuan IT, Chen JY. Role of interleukin-(IL-) 17 in the pathogenesis and targeted therapies in spondyloarthropathies. Mediators Inflamm. 2018;2018:2403935. doi: 10.1155/2018/2403935</mixed-citation><mixed-citation xml:lang="ru">Chyuan I.T., Chen J.Y. Role of interleukin-(IL-) 17 in the pathogenesis and targeted therapies in spondyloarthropathies // Mediators Inflamm. 2018. Vol. 2018. P. 2403935. doi: 10.1155/2018/2403935</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Lassiter W, Allam A. Inflammatory back pain. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.</mixed-citation><mixed-citation xml:lang="ru">Lassiter W., Allam A. Inflammatory back pain. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2023.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Gladman DD, Brubacher B, Buskila D, et al. Differences in the expression of spondyloarthropathy: А comparison between ankylosing spondylitis and psoriatic arthritis. Clin Invest Med. 1993;(16):1-7.</mixed-citation><mixed-citation xml:lang="ru">Gladman D.D., Brubacher B., Buskila D., et al. Differences in the expression of spondyloarthropathy: А comparison between ankylosing spondylitis and psoriatic arthritis // Clin Invest Med. 1993. N 16. P. 1-7.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Hojgaard P, Ellegaard K, Nielsen SM, et al. Pain mechanisms and ultrasonic inflammatory activity as prognostic factors in patients with psoriatic arthritis: A prospective cohort study. Arthritis Care Res (Hoboken). 2019;71(6):798-810. doi: 10.1002/acr.23693</mixed-citation><mixed-citation xml:lang="ru">Hojgaard P., Ellegaard K., Nielsen S.M., et al. Pain mechanisms and ultrasonic inflammatory activity as prognostic factors in patients with psoriatic arthritis: A prospective cohort study // Arthritis Care Res (Hoboken). 2019. Vol. 71, N 6. P. 798-810. doi: 10.1002/acr.23693</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Weisman MH. Inflammatory back pain: The United States perspective. Rheum Dis Clin North Am. 2012;38(3):501-512. doi: 10.1016/j.rdc.2012.09.002</mixed-citation><mixed-citation xml:lang="ru">Weisman M.H. Inflammatory back pain: The United States perspective // Rheum Dis Clin North Am. 2012. Vol. 38, N 3. P. 501-512. doi: 10.1016/j.rdc.2012.09.002</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Lindqvist U, Alenius GM, Husmark T, et al. The Swedish early psoriatic arthritis register: 2-years follow-up. A comparison with early rheumatoid arthritis. J Rheumatol. 2008;35(4):668-673.</mixed-citation><mixed-citation xml:lang="ru">Lindqvist U., Alenius G.M., Husmark T., et al. The Swedish early psoriatic arthritis register: 2-years follow-up. A comparison with early rheumatoid arthritis // J Rheumatol. 2008. Vol. 35, N 4. P. 668-673.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">Gubar EE, Loginova EY, Smirnov AV, et al. Clinical and instrumental characteristics of axial lesion in early peripheral psoriatic arthritis (data of a REMARCA study). Rheumatol Sci Pract. 2018;56(1):34-40. EDN: XPLNML doi: 10.14412/1995-4484-2018-34-40</mixed-citation><mixed-citation xml:lang="ru">Губарь Е.Е., Логинова Е.Ю., Смирнов А.В., и др. Клинико-инструментальная характеристика аксиального поражения при раннем периферическом псориатическом артрите (данные исследования РЕМАРКА) // Научно-практическая ревматология. 2018. Т. 56, № 1. С. 34-40. EDN: XPLNML doi: 10.14412/1995-4484-2018-34-40</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">Dillon CF, Hirsch R. The United States national health and nutrition examination survey and the epidemiology of ankylosing spondylitis. Am J Med Sci. 2011;341(4):281-283. doi: 10.1097/MAJ.0b013e31820f8c83</mixed-citation><mixed-citation xml:lang="ru">Dillon C.F., Hirsch R. The United States national health and nutrition examination survey and the epidemiology of ankylosing spondylitis // Am J Med Sci. 2011. Vol. 341, N 4. P. 281-283. doi: 10.1097/MAJ.0b013e31820f8c83</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">Chandran V. Psoriatic spondylitis or ankylosing spondylitis with psoriasis: Same or different? Curr Opinion Rheumatol. 2019;31(4):329-334. doi: 10.1097/BOR.0000000000000609</mixed-citation><mixed-citation xml:lang="ru">Chandran V. Psoriatic spondylitis or ankylosing spondylitis with psoriasis: Same or different? // Curr Opinion Rheumatol. 2019. Vol. 31, N 4. P. 329-334. doi: 10.1097/BOR.0000000000000609</mixed-citation></citation-alternatives></ref></ref-list></back></article>
